These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25027536)

  • 21. Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
    Bergquist PA; Hunke WA; Reed RA; Manas D; Forsyth RJ; Kenney RR; Cook J; Holahan M
    J Clin Pharm Ther; 1999 Apr; 24(2):125-32. PubMed ID: 10380064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Mar; 51(5):672-8. PubMed ID: 8203388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration.
    Foushee JA; Fox LM; Gormley LR; Lineberger MS
    Am J Health Syst Pharm; 2015 Mar; 72(6):483-6. PubMed ID: 25736944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion.
    Berti AD; Hutson PR; Schulz LT; Webb AP; Rose WE
    Am J Health Syst Pharm; 2015 Mar; 72(5):390-5. PubMed ID: 25694414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
    Monogue ML; Almarzoky Abuhussain SS; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jan; 75(1):e36-e44. PubMed ID: 29273611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    Am J Health Syst Pharm; 1997 Jun; 54(11):1295-300. PubMed ID: 9179351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatibility of verapamil hydrochloride injection in commonly used large-volume parenterals.
    Cutie MR; Lordi NG
    Am J Hosp Pharm; 1980 May; 37(5):675-6. PubMed ID: 7386476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual compatibility of common nebulizer medications with 7% sodium chloride solution.
    Fox LM; Foushee JA; Jackson DJ; Watson H
    Am J Health Syst Pharm; 2011 Jun; 68(11):1032-5. PubMed ID: 21593232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
    Trissel LA; Saenz CA; Ogundele AB; Ingram DS
    Am J Health Syst Pharm; 2004 Nov; 61(21):2289-93. PubMed ID: 15552637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration.
    Sullivan T; Forest JM; Leclair G
    Hosp Pharm; 2015 Mar; 50(3):214-20. PubMed ID: 26405311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
    Semark AJ; Venkatesh K; McWhinney BC; Pretorius C; Roberts JA; Cohen J; Venkatesh B
    Crit Care Resusc; 2013 Mar; 15(1):63-6. PubMed ID: 23432505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
    Asempa TE; Avery LM; Kidd JM; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jul; 75(14):1048-1056. PubMed ID: 29895521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
    Trissel LA; Bready BB
    Am J Hosp Pharm; 1992 Jul; 49(7):1716-9. PubMed ID: 1352424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compatibility of doripenem with other drugs during simulated Y-site administration.
    Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D
    Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.